Letters
FINE trial for CFS
Authors’ reply
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2992 (Published 09 June 2010) Cite this as: BMJ 2010;340:c2992- Alison J Wearden, reader in psychology1,
- Christopher Dowrick, professor of primary medical care2,
- Carolyn Chew-Graham, professor of primary care3,
- Richard P Bentall, professor of clinical psychology4,
- Richard K Morriss, professor of psychiatry and community mental health5,
- Sarah Peters, senior lecturer in psychology1,
- Lisa Riste, FINE trial manager1,
- Gerry Richardson, senior research fellow in health economics67,
- Karina Lovell, professor of mental health8,
- Graham Dunn, professor of biomedical statistics3
- 1School of Psychological Sciences, University of Manchester, Manchester M13 9PL
- 2School of Population, Community and Behavioural Sciences, University of Liverpool, Liverpool
- 3School of Community Based Medicine, University of Manchester, Manchester
- 4School of Psychology, University of Bangor, Adeilad Brigantia, Bangor, Gwynedd
- 5School of Community Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham
- 6Centre for Health Economics, University of York, York
- 7Hull York Medical School, University of York, Heslington, York
- 8School of Nursing, Midwifery and Social Work, University of Manchester, Manchester
- alison.wearden{at}manchester.ac.uk
We agree with Carter and other correspondents that the fatigue scale is limited by a ceiling effect, but this is more of a problem at baseline (before treatment starts) than at follow-up assessments.1 2 With the fatigue scale re-scored to 0, 1, 2, 3, we can demonstrate a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.